Abstract Background People who inject drugs (PWID) in Europe are at an increased risk of HIV/AIDS. chronic viral hepatitis B (HBV) and C (HCV). and tuberculosis (TB). We aimed to complement the evidence base on interventions optimising their care cascade with evidence from models of good practice (MoGPs) implemented in the EU/EEA and countries from the Eastern European region. https://www.ngetikin.com/special-pick-MVP4-Moisture-Vapor-Protection-Anti-Fracture-and-Noise-Reduction-Membrane-special-save/